MassHealth has told ABA providers that every line of its performance specifications is a condition of payment, hardening a Medicaid recoupment fight over the definition of supervision that is now spreading to other states. Inside the coalition's two-track response and the autism-care access cliff it warns is coming.
Key Takeaways
- MassHealth has not moved off its position: After a May 11 meeting with state officials, providers say MassHealth restated that the disputed 10-to-1 supervision standard governs 2024 claims. A program integrity official told the coalition that every element of the ABA performance specifications is a requirement of payment, an interpretation providers had not heard stated before.
- Recoupments have largely not started, but the deadline has passed: A Tufts-affiliated regional payer set May 11 as the date collection could begin, following Carelon's earlier March 27 deadline. As of mid-May, the coalition was aware of only one reported recoupment, though at least two small providers paid their assessed bills outright to remove the risk to payroll.
- Providers are fighting on two tracks at once: Rather than conceding the recoupment and negotiating only its terms, the coalition is escalating legally while also pressing a political and public-relations campaign. A budget amendment that would have paused the clawbacks was a long shot and appears to have been withdrawn during Senate budget deliberations.
- The access consequences are moving from hypothetical to imminent: Providers warn that unbudgeted six-figure clawbacks will force them to cap Medicaid caseloads, decline new MassHealth patients, and discharge the children hardest to keep above the 10-to-1 ratio: those with high cancellation rates, who are often the most vulnerable. Several member organizations say they are now at that decision point as they brace for a second bill covering 2025.
When a state Medicaid program recovers money it believes it paid in error, the term of art is “recoupment,” a word that implies a quiet ledger correction. For Applied Behavior Analysis providers in Massachusetts, the months since the first recoupment letters arrived have felt less like a correction than a standoff. As Acuity reported in April, MassHealth directed its managed care entities to claw back 2024 payments from providers whose billed supervision fell below one hour of Licensed Applied Behavior Analyst time for every ten hours of direct technician service. In the weeks since, a great deal of activity has produced almost no movement in the underlying dispute.
“It's a bit of a paradox that lots has happened, and nothing has happened all at the same time,” said Rebecca L. Thompson, PhD, BCBA-D, a representative of Massachusetts Providers for ABA Access and Quality (MPAAQ), the coalition coordinating the provider response, who sat down with Acuity Media Network to discuss the standoff. “Lots of effort has gone into this issue, but there's no change or progress in the status since the last time we spoke.”
The chronology has been one of shifting deadlines. Carelon Behavioral Health, acting on MassHealth's direction, first told providers they owed repayment by March 27, with rebuttals due later: payment ahead of any resolved appeal. In early April, a smaller regional payer affiliated with Tufts Health Plan issued letters with a more conventional sequence, giving two weeks to rebut and four weeks before collection could begin. That second deadline landed on May 11.
As of mid-May, the shoe had mostly not dropped. The coalition said it was aware of only a single reported recoupment, with multiple providers still receiving payments as usual. “Everyone is waiting for the shoe to drop, and that could happen at any moment,” Thompson said. At least two small providers chose to pay their assessed bills outright, not as an admission the findings were correct, but because the certainty of a settled bill beat the risk of a withheld payment and a missed payroll.
MassHealth Hardens Its ABA Supervision Stance: “Everything in The Performance Specifications Is a Requirement of Payment”
The pivotal development since April was a May 11 meeting between coalition members and two MassHealth officials: Lee Robinson and Charlie Patton, who handles program integrity and led most of the discussion. According to the coalition, Patton stated that all elements of the ABA performance specifications, the roughly six-page document MassHealth cites as the basis for the audit, are requirements of payment. The supervision standard amounts to about two sentences within that document.
To providers, that interpretation was both new and alarming. “That hasn't been said in writing or said out loud previously,” Thompson said. If a stray provision about supervision can support a clawback of already-paid claims, the reasoning goes, then any other line in the specifications could be invoked the same way. “That means that whole document is something that at any time they could pull out and say, if you didn't do this one piece, we're going to recoup those funds even though you provided the service.”
The dispute turns on whether the specifications functioned as a binding rule or as clinical guidance. Providers note that the document in effect for 2024 read like a prior-authorization guideline, that it never went through a formal regulatory or public-comment process, and that even the 2026 version does not name CPT codes 97155 and 97153 in its supervision requirement. They understood it to describe case supervision broadly, not a narrow ratio of two billing codes. MassHealth has insisted the expectation was clear all along and represents no change in policy. Providers also point to a track record that, in their telling, cuts against the surprise: under the Carelon umbrella, MBHP, the largest plan within MassHealth, had held quarterly meetings reviewing supervision ratios in aggregate and told multiple organizations they were meeting or exceeding expectations, averaging supervision in the 13-to-15 percent range. What those reviews never did, the coalition says, was examine compliance at the individual-client level, the basis on which the 2024 audit now finds fault.
Fighting the Medicaid Recoupment on Two Tracks: The FY27 Budget, Litigation, and a Family Campaign
Asked whether the coalition was pivoting away from contesting the recoupment toward merely softening its terms, Thompson was firm that the effort runs on two tracks at once. The first has been political. At the coalition's suggestion, State Senator Joan Lovely filed a budget amendment that would have barred MassHealth from recouping on these services for calendar years 2024, 2025, and 2026, and required the agency to report to legislative committees on the legal basis for the clawbacks. Roughly twenty companies submitted letters in support. The coalition always regarded it as a long shot. “We knew it was very unlikely that would actually end up in the budget,” Thompson said, describing it as “really about raising awareness” and applying pressure. The amendment's status on the legislature's website appeared as withdrawn during the Senate's budget deliberations this week, an outcome the coalition said would be unsurprising even as it continued to press other legislators. The broader governance fight over who speaks for the ABA field has sharpened the stakes of that advocacy.
The second track is legal, and the coalition stresses it did not start there: it escalated only once it became clear MassHealth was not engaging in good faith. A March litigation-threat letter from the firm Krokidas & Bluestein, addressed to Carelon and copying MassHealth leadership, drew what the coalition described as a game of “hot potato”: Carelon replied to say the matter should be directed to MassHealth, which had been copied on the original letter and has not provided a targeted written response. What providers did receive was an undated, unaddressed document, apparently drafted in response to a request from the health plans, that restated the audit's parameters without offering new information or a remedy. The coalition says it is now weighing its next legal steps with its attorneys, in part to test whether the recoupment is “really legally defensible, which we have a lot of serious questions about.” The statutory argument centers on M.G.L. c. 118E, which limits retroactive claims denial after twelve months to circumstances such as fraud, non-delivery, or non-compliance with regulations, and the coalition's contention that performance specifications are not regulations.
A third effort is taking shape alongside the others: a more coordinated public-relations campaign built around families. The argument is nuanced, Thompson acknowledged, because the immediate harm falls on providers while the long-term harm falls on patients. The coalition is identifying families willing to speak publicly, in the hope that putting a face on the consequences will move MassHealth where logical arguments about access have not. Underlying all three tracks is a posture the coalition stresses repeatedly: it supports program integrity and wants guardrails, but ones applied with “surgical precision” to genuine outliers rather than as “a blunt instrument across the whole network.”
The Autism-Care Access Cliff: How ABA Recoupment Threatens Medicaid Caseloads
The coalition's central warning is that the recoupment's true cost will be measured in discharged children, not returned dollars. The mechanism is straightforward. Faced with an unbudgeted bill for 2024 and the expectation of a similar one for 2025, a provider has limited ways to stop the bleeding. Some will stop accepting new MassHealth patients to shift their payer mix toward less risk; others will discharge clients early. The children most likely to be cut, the coalition says, are precisely those facing the steepest socioeconomic barriers, because high cancellation rates make the 10 percent supervision threshold hardest to hit despite a provider's best efforts. The threshold is harder still to hold during the ongoing ABA workforce shortage, when a supervisor's departure or leave can pull a caseload below the line before a replacement is credentialed.
Thompson offered concrete cases. A family living under a restraining order, where services can be canceled on a moment's notice, is exactly the kind of high-need household for which continuity matters most and a rigid annual ratio is hardest to maintain. Families in shelters can often be served only one staff member at a time, ruling out a technician and a supervising analyst in the same session, and telehealth supervision may be impossible where recording is not permitted. A historic February snowstorm that shuttered services across the Northeast offered a mundane version of the same problem: a missed monthly supervision visit that cannot be made up can tip a low-intensity case below threshold through no fault of the provider.
Those consequences remain prospective, which is part of why they have not yet moved the agency. But the further the dispute drags out, Thompson said, the more imminent they become. In a member meeting earlier in the week, companies described themselves as at a genuine decision point, holding a 2024 bill, anticipating a 2025 bill, and trying to plan for 2026. The reimbursement backdrop sharpens the math: in testimony before the Joint Committee on Health Care Financing, MassABA put Massachusetts direct-ABA reimbursement at roughly 65 dollars an hour, below comparable states such as Maryland, leaving little margin to absorb a retroactive clawback.
Massachusetts is not alone in scrutinizing ABA supervision, and the coalition sees a revealing contrast in how other states are doing it. North Carolina's newly enacted Medicaid ABA law, House Bill 696, signed April 30, directs the state to set explicit treatment-to-supervision ratios through rulemaking, alongside in-person assessment requirements, a telehealth supervision cap, and limits on out-of-state providers. Indiana's ABA overhaul, effective in April, layers supervision-ratio requirements onto phased rate cuts and new accreditation mandates. The common thread the coalition draws is that those states are writing their standards into statute and rule up front rather than enforcing an uncodified one against a year of already-paid claims. Thompson said Indiana had also moved to specify that its requirement is case supervision rather than a narrow billing-code ratio, a distinction Massachusetts has not drawn. “At least other states are getting wise to being more specific in their plan so that future recoupments are more justified,” she said, while declining to speculate on whether Massachusetts will follow suit. Her concern is that MassHealth has consistently defended vague language as an intentional floor, even as providers experience the vagueness as a ceiling that quietly limits care. That federal-and-state wave of ABA documentation audits is reshaping the field, with several states pursuing Medicaid fraud and overpayment enforcement against ABA providers at once.
For now, the standoff holds. The coalition keeps extending its hand toward collaboration, Thompson said, even as it prepares to escalate, because the alternative is to do nothing while access erodes. Whether MassHealth, having committed publicly to its reading of the rule, can find an off-ramp that lets both sides save face remains the open question, at a moment when other states are pressing their own Medicaid ABA enforcement and providers increasingly find these disputes settled in court rather than across a table.
